Literature DB >> 18718848

Therapeutics for neonatal brain injury.

Fernando F Gonzalez1, Donna M Ferriero.   

Abstract

Neonatal brain injury is an important cause of death and neurodevelopmental delay. Multiple pathways of oxidant stress, inflammation, and excitotoxicity lead to both early and late phases of cell damage and death. Therapies targeting these different pathways have shown potential in protecting the brain from ongoing injury. More recent therapies, such as growth factors, have demonstrated an ability to increase cell proliferation and repair over longer periods of time. Even though hypothermia, which decreases cerebral metabolism and possibly affects other mechanisms, may show some benefit in particular cases, no widely effective therapeutic interventions for human neonates exist. In this review, we summarize recent findings in neuroprotection and neurogenesis for the immature brain, including combination therapy to optimize repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718848     DOI: 10.1016/j.pharmthera.2008.07.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  31 in total

1.  Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Authors:  Wanqiu Chen; Qingyi Ma; Hidenori Suzuki; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2011-01-27       Impact factor: 7.914

2.  Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke.

Authors:  Damjan Osredkar; Jeffrey W Sall; Philip E Bickler; Donna M Ferriero
Journal:  Neurobiol Dis       Date:  2010-02-01       Impact factor: 5.996

3.  The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats.

Authors:  Nirelia M Idrus; Nancy N H McGough; Michael J Spinetta; Jennifer D Thomas; Edward P Riley
Journal:  Neurotoxicol Teratol       Date:  2011-05-03       Impact factor: 3.763

Review 4.  Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.

Authors:  Marcel P H van den Broek; Floris Groenendaal; Antoine C G Egberts; Carin M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

5.  Early antioxidant treatment and delayed hypothermia after hypoxia-ischemia have no additive neuroprotection in newborn pigs.

Authors:  Xinli Ni; Zeng-Jin Yang; Bing Wang; Erin L Carter; Abby C Larson; Lee J Martin; Raymond C Koehler
Journal:  Anesth Analg       Date:  2012-06-28       Impact factor: 5.108

6.  Striatal neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone.

Authors:  Xinli Ni; Zeng-Jin Yang; Erin L Carter; Lee J Martin; Raymond C Koehler
Journal:  Dev Neurosci       Date:  2011-06-24       Impact factor: 2.984

7.  Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.

Authors:  Hannah X Chu; Nicole M Jones
Journal:  Neurochem Res       Date:  2015-06-25       Impact factor: 3.996

8.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

9.  Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.

Authors:  Christopher M Traudt; Ronald J McPherson; Larry A Bauer; Todd L Richards; Thomas M Burbacher; Ryan M McAdams; Sandra E Juul
Journal:  Dev Neurosci       Date:  2013-11-01       Impact factor: 2.984

10.  Ex vivo gene therapy using intravitreal injection of GDNF-secreting mouse embryonic stem cells in a rat model of retinal degeneration.

Authors:  Kevin Gregory-Evans; Francis Chang; Matthew D Hodges; Cheryl Y Gregory-Evans
Journal:  Mol Vis       Date:  2009-05-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.